Delivery Order SPE2DB20D2104-SPE2DB23FR74D

Award Date 1/10/23
Potential Completion Date 1/11/23
Potential Value $1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ivermectin 1% cream, 45 grams, valued at $2,820.78. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,129.68, is for the delivery of Ivermectin 1% Cream 45GM, a medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award, with ID SPE2DB24D3013|SPE2DB25FFLMZ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ivermectin 1% cream 45g. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has a ceiling value of $1,089.69. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,528.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ivermectin 1% Cream, 45GM, a medical product used for various therapeutic purposes. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 9, 2025. It is not designated as a set-aside contract, indicating...
This federal contract award, valued at $2,402.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ivermectin 1% Cream, 45 gm, a pharmaceutical product, to support government medical requirements. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 8, 2025. The contract is not designated as a set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,552.84 firm fixed-price contract is for the delivery of Ivermectin 1% cream, a medication used to treat certain skin conditions. The contract is not designated as a set-aside and is therefore open to full and open competition. It has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp is the prime contractor and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ivermectin 1% 45gm medication, with a ceiling value of $3,143.25 and a period of performance through May 30, 2025. The contract is a firm-fixed-price delivery order and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Opzelura 1.5% cream, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $6,019.85 firm fixed-price contract has a completion date of December 4, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,280.56 firm fixed-price delivery order is for the provision of Pimecrolimus 1% Cream, a pharmaceutical product, with a completion date of February 13, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order for pharmaceutical products valued at $15,113.61. The contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of February 14, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This single-award IDC serves as the primary...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FR74D
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ivermectin 1% cream, 45 grams, to support U.S. government healthcare programs. The $1,030.14 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has a completion date of January 11, 2023.

The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare facilities worldwide. This IDC, which runs through December 2025, enables the DLA to efficiently procure essential medications and medical commodities to support the healthcare needs of U.S. military personnel and veterans.

The contract award does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 2/27/25, 10:31 AM